These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20434013)

  • 41. Cancer-associated thrombosis.
    Sood SL
    Curr Opin Hematol; 2009 Sep; 16(5):378-85. PubMed ID: 19606029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Computational modeling of thrombotic microparticle deposition in nonparallel flow regimes.
    Hall CL; Calt M
    J Biomech Eng; 2014 Nov; 136(11):. PubMed ID: 25085867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microparticle-associated tissue factor activity in cancer patients with and without thrombosis.
    Tesselaar ME; Romijn FP; van der Linden IK; Bertina RM; Osanto S
    J Thromb Haemost; 2009 Aug; 7(8):1421-3. PubMed ID: 19500241
    [No Abstract]   [Full Text] [Related]  

  • 44. Pathogenesis of thrombotic disorders in patients with cancer.
    Sallah S; Ahmad O; Kaiser HE
    In Vivo; 2000; 14(1):251-3. PubMed ID: 10757083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of membrane lipids in the induction of macrophage apoptosis by microparticles.
    Huber LC; Jüngel A; Distler JH; Moritz F; Gay RE; Michel BA; Pisetsky DS; Gay S; Distler O
    Apoptosis; 2007 Feb; 12(2):363-74. PubMed ID: 17191114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors.
    Soleti R; Benameur T; Porro C; Panaro MA; Andriantsitohaina R; Martínez MC
    Carcinogenesis; 2009 Apr; 30(4):580-8. PubMed ID: 19168578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apoptosis as a determinant of atherothrombosis.
    Tedgui A; Mallat Z
    Thromb Haemost; 2001 Jul; 86(1):420-6. PubMed ID: 11487033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microvesicles and Cancer Associated Thrombosis.
    Lacroix R; Vallier L; Bonifay A; Simoncini S; Mege D; Aubert M; Panicot-Dubois L; Dubois C; Dignat-George F
    Semin Thromb Hemost; 2019 Sep; 45(6):593-603. PubMed ID: 31430786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITP.
    Fontana V; Jy W; Ahn ER; Dudkiewicz P; Horstman LL; Duncan R; Ahn YS
    Thromb Res; 2008; 122(5):599-603. PubMed ID: 18334267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamics of circulating microparticles in liver transplant patients.
    Brodsky SV; Facciuto ME; Heydt D; Chen J; Islam HK; Kajstura M; Ramaswamy G; Aguero-Rosenfeld M
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):261-8. PubMed ID: 18836617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
    Sud R; Khorana AA
    Thromb Res; 2009; 123 Suppl 4():S18-21. PubMed ID: 19303497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of microparticles in atherothrombosis.
    Leroyer AS; Tedgui A; Boulanger CM
    J Intern Med; 2008 May; 263(5):528-37. PubMed ID: 18410596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microparticles and Exercise in Clinical Populations.
    Highton PJ; Martin N; Smith AC; Burton JO; Bishop NC
    Exerc Immunol Rev; 2018; 24():46-58. PubMed ID: 29461971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
    Lee AY
    Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
    Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
    Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles.
    Smalley DM; Root KE; Cho H; Ross MM; Ley K
    Thromb Haemost; 2007 Jan; 97(1):67-80. PubMed ID: 17200773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microparticles and arterial disease.
    Blann A; Shantsila E; Shantsila A
    Semin Thromb Hemost; 2009 Jul; 35(5):488-96. PubMed ID: 19739039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A new look at platelets and microparticles, including their role in haemostatic disorders and progression of neoplastic disease].
    Łuksza E; Mantur M
    Pol Merkur Lekarski; 2009 Dec; 27(162):491-5. PubMed ID: 20120715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Red cell PMVs, plasma membrane-derived vesicles calling out for standards.
    Hind E; Heugh S; Ansa-Addo EA; Antwi-Baffour S; Lange S; Inal J
    Biochem Biophys Res Commun; 2010 Sep; 399(4):465-9. PubMed ID: 20674549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Apoptosis, a major determinant of atherothrombosis.
    Tedgui A; Mallat Z
    Arch Mal Coeur Vaiss; 2003 Jun; 96(6):671-5. PubMed ID: 12868350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.